Profile | GDS4284 / 1558476_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 727.067 | 70 |
GSM687648 | Patient 402 control | 682.502 | 68 |
GSM687653 | Patient 403 control | 742.606 | 70 |
GSM687658 | Patient 404 control | 504.794 | 64 |
GSM687663 | Patient 411 control | 450.861 | 61 |
GSM687668 | Patient 422 control | 642.002 | 67 |
GSM687673 | Patient 424 control | 570.076 | 65 |
GSM687678 | Patient 425 control | 401.474 | 59 |
GSM687683 | Patient 427 control | 465.661 | 61 |
GSM687688 | Patient 428 control | 703.329 | 69 |
GSM687695 | Patient 441 control | 306.52 | 50 |
GSM687699 | Patient 443 control | 625.064 | 66 |
GSM687704 | Patient 444 control | 636.813 | 67 |
GSM687707 | Patient 448 control | 772.752 | 70 |
GSM687712 | Patient 449 control | 412.644 | 60 |
GSM687719 | Patient 450 control | 609.932 | 66 |
GSM687724 | Patient 451 control | 744.197 | 70 |
GSM687728 | Patient 452 control | 542.399 | 65 |
GSM687646 | Patient 401 treated 24h | 621.616 | 66 |
GSM687649 | Patient 402 treated 24h | 662.901 | 68 |
GSM687665 | Patient 411 treated 24h | 658.679 | 67 |
GSM687651 | Patient 402 treated 4 weeks | 435.162 | 61 |
GSM687667 | Patient 411 treated 4 weeks | 669.188 | 67 |
GSM687670 | Patient 422 treated 24h | 577.824 | 65 |
GSM687671 | Patient 422 treated 4 weeks | 432.935 | 61 |
GSM687654 | Patient 403 treated 24h | 554.836 | 66 |
GSM687675 | Patient 424 treated 24h | 361.645 | 57 |
GSM687685 | Patient 427 treated 24h | 736.28 | 69 |
GSM687656 | Patient 403 treated 4 weeks | 599.649 | 67 |
GSM687677 | Patient 424 treated 4 weeks | 548.361 | 65 |
GSM687687 | Patient 427 treated 4 weeks | 571.901 | 65 |
GSM687692 | Patient 428 treated 4h | 594.656 | 66 |
GSM687716 | Patient 449 treated 4h | 482.998 | 64 |
GSM687722 | Patient 450 treated 4h | 515.666 | 63 |
GSM687680 | Patient 425 treated 24h | 492.544 | 63 |
GSM687690 | Patient 428 treated 24h | 524.213 | 65 |
GSM687700 | Patient 443 treated 24h | 356.993 | 54 |
GSM687705 | Patient 444 treated 24h | 494.738 | 64 |
GSM687714 | Patient 449 treated 24h | 351.549 | 59 |
GSM687721 | Patient 450 treated 24h | 512.474 | 63 |
GSM687682 | Patient 425 treated 4 weeks | 469.728 | 63 |
GSM687694 | Patient 428 treated 4 weeks | 459.677 | 62 |
GSM687702 | Patient 443 treated 4 weeks | 461.27 | 61 |
GSM687718 | Patient 449 treated 4 weeks | 340.561 | 58 |
GSM687723 | Patient 450 treated 4 weeks | 662.698 | 68 |
GSM687661 | Patient 404 treated 4h | 486.382 | 63 |
GSM687710 | Patient 448 treated 4h | 520.389 | 65 |
GSM687726 | Patient 451 treated 4h | 533.134 | 64 |
GSM687730 | Patient 452 treated 4h | 287.532 | 40 |
GSM687660 | Patient 404 treated 24h | 188.179 | 43 |
GSM687697 | Patient 441 treated 24h | 220.013 | 44 |
GSM687709 | Patient 448 treated 24h | 453.159 | 62 |
GSM687725 | Patient 451 treated 24h | 704.435 | 69 |
GSM687729 | Patient 452 treated 24h | 169.924 | 38 |
GSM687727 | Patient 451 treated 4 weeks | 870.402 | 72 |
GSM687731 | Patient 452 treated 4 weeks | 319.84 | 55 |